Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swen Hesse

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Scientific Reports|December 8, 2020
Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesityRico Grundmann, Michael Rullmann, Julia Luthardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2020
Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertensionArmin Frille, Michael Rullmann, Georg-Alexander Becker, et al.
Frontiers in Nuclear Medicine|March 6, 2026
Rethinking dynamics: static amino acid PET parameters vs. dynamic amino acid PET parameters for the detection of tumor progression in patients with post-treatment gliomaDylan Henssen, Michael Rullmann, Andreas Schildan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 8, 2016
Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer's diseaseTobias Tuszynski, Michael Rullmann, Julia Luthardt, et al.
The European Journal of Neuroscience|August 14, 2016
Effortful control as a dimension of temperament is negatively associated with prefrontal serotonin transporter availability in obese and non-obese individualsFranziska Zientek, Karsten Winter, Astrid Müller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 31, 2016
Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's diseaseSolveig Tiepolt, Swen Hesse, Marianne Patt, et al.
European Radiology|February 27, 2015
Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphyCatharina Lange, Jens Kurth, Anita Seese, et al.
Translational Psychiatry|November 17, 2019
Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[<sup>11</sup>C]methylreboxetine positron emission tomography studyChristine Ulke, Michael Rullmann, Jue Huang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 31, 2020
Unravelling the effects of methylphenidate on the dopaminergic and noradrenergic functional circuitsOttavia Dipasquale, Daniel Martins, Arjun Sethi, et al.
Cancers|June 26, 2025
Retrospective Evaluation of Baseline Amino Acid PET for Identifying Future Regions of Tumor Recurrence in High-Grade Glioma PatientsDylan Henssen, Michael Rullmann, Andreas Schildan, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Scientific Reports|December 8, 2020
Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesityRico Grundmann, Michael Rullmann, Julia Luthardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2020
Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertensionArmin Frille, Michael Rullmann, Georg-Alexander Becker, et al.
Frontiers in Nuclear Medicine|March 6, 2026
Rethinking dynamics: static amino acid PET parameters vs. dynamic amino acid PET parameters for the detection of tumor progression in patients with post-treatment gliomaDylan Henssen, Michael Rullmann, Andreas Schildan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 8, 2016
Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer's diseaseTobias Tuszynski, Michael Rullmann, Julia Luthardt, et al.
The European Journal of Neuroscience|August 14, 2016
Effortful control as a dimension of temperament is negatively associated with prefrontal serotonin transporter availability in obese and non-obese individualsFranziska Zientek, Karsten Winter, Astrid Müller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 31, 2016
Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's diseaseSolveig Tiepolt, Swen Hesse, Marianne Patt, et al.
European Radiology|February 27, 2015
Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphyCatharina Lange, Jens Kurth, Anita Seese, et al.
Translational Psychiatry|November 17, 2019
Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[<sup>11</sup>C]methylreboxetine positron emission tomography studyChristine Ulke, Michael Rullmann, Jue Huang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 31, 2020
Unravelling the effects of methylphenidate on the dopaminergic and noradrenergic functional circuitsOttavia Dipasquale, Daniel Martins, Arjun Sethi, et al.
Cancers|June 26, 2025
Retrospective Evaluation of Baseline Amino Acid PET for Identifying Future Regions of Tumor Recurrence in High-Grade Glioma PatientsDylan Henssen, Michael Rullmann, Andreas Schildan, et al.
Pageof 12